<DOC>
	<DOCNO>NCT01634360</DOCNO>
	<brief_summary>A 48-month open label multi-centered extension study evaluate long-term safety , tolerability efficacy E2007 patient Parkinson 's Disease `` wear '' motor fluctuation `` '' period Dyskinesias .</brief_summary>
	<brief_title>Long-Term Safety , Tolerability Efficacy Perampanel Treated Parkinson 's Disease Patients With Motor Fluctuations</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Patients enrol Study E2007E044204 either complete 12 week study drug treatment withdrew study due lack efficacy . Pregnant lactating woman . Women child bear potential unless infertile ( include surgically sterile ) practice effective contraception ( e.g . abstinence , IUDintrauterine device , barrier method plus hormonal method ) . These patient must also willing remain current form contraception duration study . Postmenopausal woman may recruit must amenorrhoeic least 1 year consider nonchild bear potential . Fertile men willing use reliable contraception fertile men partner willing use reliable contraception . These patient partner must also willing remain use reliable contraception duration study . Patients past present history drug alcohol abuse . Patients past ( within one year ) present history psychotic symptom require antipsychotic treatment . Patients may take antidepressant medication , however dose must keep stable least 8 week prior baseline visit . Patients unstable abnormality hepatic , renal , cardiovascular , respiratory , gastrointestinal , haematological , endocrine metabolic system might complicate assessment tolerability study medication . Patients significantly elevate liver enzyme ( abnormal bilirubin serum transaminase level 1.5 time upper normal limit ) . Patients current prior treatment ( within 4 week prior Baseline visit ) medication know induce enzyme cytochrome P450 3A4 include limit ; carbamazepine ; dexamethasone ; ethosuximide ; phenobarbital ; phenytoin ; primidone ; rifabutin ; rifampicin ; St John 's Wort . Current prior treatment ( within 4 week prior baseline visit ) methyldopa , budipine , reserpine intermittent use liquid form levodopa need ( prn ) apomorphine . Patients previous stereotactic surgery ( e.g . pallidotomy ) Parkinson 's disease likely undergo surgery Parkinson 's disease participating study . Patients receive deep brain stimulation ( DBS ) likely undergo DBS Parkinson 's disease participate extension study . Patients clinically significant cognitive impairment ( minimental state examination ( MMSE ) &lt; 24 /or fulfil diagnostic statistical manual mental disorder ( DSM IV ) criterion dementia due Parkinson 's disease ) . Patients condition affect peripheral central sensory system .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>